Explosive nosocomial outbreak of SARS-CoV-2 in a rehabilitation clinic: the limits of genomics for outbreak reconstruction.

COVID-19 Healthcare-associated infection Infection prevention and control Long-term care facilities Nosocomial outbreaks SARS-CoV-2

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 25 06 2021
accepted: 27 07 2021
pubmed: 31 8 2021
medline: 11 11 2021
entrez: 30 8 2021
Statut: ppublish

Résumé

Nosocomial outbreaks of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are frequent despite implementation of conventional infection control measures. An outbreak investigation was undertaken using advanced genomic and statistical techniques to reconstruct likely transmission chains and assess the role of healthcare workers (HCWs) in SARS-CoV-2 transmission. A nosocomial SARS-CoV-2 outbreak in a university-affiliated rehabilitation clinic was investigated, involving patients and HCWs, with high coverage of pathogen whole-genome sequences (WGS). The time-varying reproduction number from epidemiological data (R The outbreak lasted from 14 This outbreak report highlights the essential role of HCWs in SARS-CoV-2 transmission dynamics in healthcare settings. Limited genetic diversity in pathogen genomes hampered the reconstruction of individual transmission events, resulting in substantial uncertainty in who infected whom. However, this study shows that despite such uncertainty, significant transmission patterns can be observed.

Sections du résumé

BACKGROUND BACKGROUND
Nosocomial outbreaks of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are frequent despite implementation of conventional infection control measures. An outbreak investigation was undertaken using advanced genomic and statistical techniques to reconstruct likely transmission chains and assess the role of healthcare workers (HCWs) in SARS-CoV-2 transmission.
METHODS METHODS
A nosocomial SARS-CoV-2 outbreak in a university-affiliated rehabilitation clinic was investigated, involving patients and HCWs, with high coverage of pathogen whole-genome sequences (WGS). The time-varying reproduction number from epidemiological data (R
FINDINGS RESULTS
The outbreak lasted from 14
INTERPRETATION CONCLUSIONS
This outbreak report highlights the essential role of HCWs in SARS-CoV-2 transmission dynamics in healthcare settings. Limited genetic diversity in pathogen genomes hampered the reconstruction of individual transmission events, resulting in substantial uncertainty in who infected whom. However, this study shows that despite such uncertainty, significant transmission patterns can be observed.

Identifiants

pubmed: 34461177
pii: S0195-6701(21)00308-X
doi: 10.1016/j.jhin.2021.07.013
pmc: PMC8393517
pii:
doi:

Substances chimiques

Explosive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-134

Subventions

Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19065
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Mol Biol Evol. 1992 Jul;9(4):678-87
pubmed: 1630306
JPEN J Parenter Enteral Nutr. 2019 Feb;43(2):181-193
pubmed: 30288759
Infect Control Hosp Epidemiol. 2020 Jul;41(7):866-867
pubmed: 32223768
Swiss Med Wkly. 2021 Feb 15;151:w20475
pubmed: 33638351
Lancet Infect Dis. 2020 Nov;20(11):1273-1280
pubmed: 32622380
Clin Infect Dis. 2021 Jun 1;72(11):e727-e735
pubmed: 32954414
Infect Control Hosp Epidemiol. 2021 Jan 11;:1-2
pubmed: 33427151
BMC Bioinformatics. 2018 Oct 22;19(Suppl 11):363
pubmed: 30343663
J Am Geriatr Soc. 2008 Oct;56(10):1926-31
pubmed: 18811613
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
J Am Med Dir Assoc. 2020 Nov;21(11):1546-1554.e3
pubmed: 33138936
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Lancet. 2021 Feb 6;397(10273):445
pubmed: 33549175
JAMA Intern Med. 2020 Dec 1;180(12):1709-1711
pubmed: 33074318
Antimicrob Resist Infect Control. 2021 Jan 6;10(1):7
pubmed: 33407833
J Infect. 2021 Oct;83(4):473-482
pubmed: 34332019
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Ann Intern Med. 2021 Jun;174(6):794-802
pubmed: 33556277
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
BMC Med. 2020 Jun 25;18(1):194
pubmed: 32586323
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
PLoS Comput Biol. 2014 Jan;10(1):e1003457
pubmed: 24465202
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
Lancet Infect Dis. 2007 Apr;7(4):282-8
pubmed: 17376385
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Clin Infect Dis. 2021 Sep 15;73(6):e1329-e1336
pubmed: 33857303
Elife. 2021 Mar 17;10:
pubmed: 33729154
J Am Med Dir Assoc. 2012 Mar;13(3):272-8
pubmed: 21450226
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1337-1344
pubmed: 32298146

Auteurs

M Abbas (M)

Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK. Electronic address: mohamed.abbas@hcuge.ch.

T Robalo Nunes (T)

Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland; Serviço de Infecciologia, Hospital Garcia de Orta, EPE, Almada, Portugal.

A Cori (A)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK; The Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK.

S Cordey (S)

Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.

F Laubscher (F)

Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland.

S Baggio (S)

Division of Prison Health, Geneva University Hospitals, Geneva, Switzerland; Office of Correction, Department of Justice and Home Affairs of the Canton of Zurich, Zurich, Switzerland.

T Jombart (T)

The Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK; Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

A Iten (A)

Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland.

L Vieux (L)

Occupational Health Service, Geneva University Hospitals, Geneva, Switzerland.

D Teixeira (D)

Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland.

M Perez (M)

Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland.

D Pittet (D)

Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.

E Frangos (E)

Clinique de Joli-Mont, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.

C E Graf (CE)

Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.

W Zingg (W)

Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland; Infection Control Programme, Zurich University Hospital, Zurich, Switzerland.

S Harbarth (S)

Infection Control Programme, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH